litlas
ログインアカウント作成

David A. Luckenbaugh

1998–2020 年に発表

89
論文数
21,287
被引用数
81
h 指数
87
i10 指数

被引用数

David A. Luckenbaugh の年別被引用数1990 年: 被引用 1 件1997 年: 被引用 1 件1998 年: 被引用 1 件2000 年: 被引用 2 件2001 年: 被引用 7 件2002 年: 被引用 16 件2003 年: 被引用 36 件2004 年: 被引用 40 件2005 年: 被引用 91 件2006 年: 被引用 165 件2007 年: 被引用 184 件2008 年: 被引用 240 件2009 年: 被引用 296 件2010 年: 被引用 245 件2011 年: 被引用 286 件2012 年: 被引用 340 件2013 年: 被引用 396 件2014 年: 被引用 378 件2015 年: 被引用 477 件2016 年: 被引用 328 件2017 年: 被引用 283 件2018 年: 被引用 314 件2019 年: 被引用 674 件2020 年: 被引用 790 件2021 年: 被引用 622 件2022 年: 被引用 493 件2023 年: 被引用 309 件2024 年: 被引用 449 件2025 年: 被引用 187 件2026 年: 被引用 1 件1991〜1996 年は被引用が無いため表示していません1999 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,302 件、この内訳の 32.4%イギリス: 引用元論文 485 件、この内訳の 6.8%カナダ: 引用元論文 478 件、この内訳の 6.7%中国: 引用元論文 443 件、この内訳の 6.3%ドイツ: 引用元論文 349 件、この内訳の 4.9%イタリア: 引用元論文 274 件、この内訳の 3.9%オーストラリア: 引用元論文 212 件、この内訳の 3%オランダ: 引用元論文 208 件、この内訳の 2.9%ブラジル: 引用元論文 196 件、この内訳の 2.8%日本: 引用元論文 191 件、この内訳の 2.7%スペイン: 引用元論文 184 件、この内訳の 2.6%フランス: 引用元論文 179 件、この内訳の 2.5%
0%32.4%その他 22.5%

機関

分野

  • Medicine49.9%
  • Neuroscience35%
  • Psychology9.4%
  • Biochemistry, Genetics and Molecular Biology3.5%
  • Computer Science0.6%
  • Health Professions0.3%
  • その他1.3%

トピック

  • Treatment of Major Depression14.1%
  • Tryptophan and brain disorders11.6%
  • Bipolar Disorder and Treatment6.7%
  • Neuroscience and Neuropharmacology Research5.5%
  • Stress Responses and Cortisol4.4%
  • Neurotransmitter Receptor Influence on Behavior4.4%
  • その他53.3%

共著者

全論文

検索で開く
  1. A Randomized Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Major Depression

    著者: Carlos A. Zarate, Jaskaran Singh, Paul J. Carlson, Nancy E. Brutsché, Rezvan Ameli, David A. Luckenbaugh, Dennis S. Charney, Husseini K. Manji - Archives of General Psychiatry 2006 被引用: 3,753

  2. A Randomized Add-on Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Bipolar Depression

    著者: Nancy Diazgranados, Lobna Ibrahim, Nancy E. Brutsché, Andrew B. Newberg, Phillip D. Kronstein, Sami Khalife, William Kammerer, Zenaide Quezado, David A. Luckenbaugh, Giacomo Salvadore, Rodrigo Machado‐Vieira, Husseini K. Manji, Carlos A. Zarate - Archives of General Psychiatry 2010 被引用: 969

  3. Replication of Ketamine's Antidepressant Efficacy in Bipolar Depression: A Randomized Controlled Add-On Trial

    著者: Carlos A. Zarate, Nancy E. Brutsché, Lobna Ibrahim, Jose Franco‐Chaves, Nancy Diazgranados, Anibal Cravchik, Jessica Selter, Craig A. Marquardt, Victoria Liberty, David A. Luckenbaugh - Biological Psychiatry 2012 被引用: 817

  4. Do the dissociative side effects of ketamine mediate its antidepressant effects?

    著者: David A. Luckenbaugh, Mark J. Niciu, Dawn F. Ionescu, Neal M. Nolan, Erica M. Richards, Nancy E. Brutsché, Sara Guevara, Carlos A. Zarate - Journal of Affective Disorders 2014 被引用: 282

  5. Rapid Resolution of Suicidal Ideation After a Single Infusion of anN-Methyl-D-Aspartate Antagonist in Patients With Treatment-Resistant Major Depressive Disorder

    著者: Nancy Diazgranados, Lobna Ibrahim, Nancy E. Brutsché, Rezvan Ameli, Ioline D. Henter, David A. Luckenbaugh, Rodrigo Machado‐Vieira, Carlos A. Zarate - The Journal of Clinical Psychiatry 2010 被引用: 563

  6. Features of dissociation differentially predict antidepressant response to ketamine in treatment-resistant depression

    著者: Mark J. Niciu, Bridget Shovestul, Brittany A. Jaso, Cristan Farmer, David A. Luckenbaugh, Nancy E. Brutsché, Lawrence T. Park, Elizabeth D. Ballard, Carlos A. Zarate - Journal of Affective Disorders 2018 被引用: 133

  7. Relationship of Ketamine's Plasma Metabolites with Response, Diagnosis, and Side Effects in Major Depression

    著者: Carlos A. Zarate, Nancy E. Brutsché, Gonzalo Laje, David A. Luckenbaugh, Swarajya Lakshmi Vattem Venkata, Anuradha Ramamoorthy, Ruin Moaddel, Irving W. Wainer - Biological Psychiatry 2012 被引用: 283

  8. Anti-anhedonic effect of ketamine and its neural correlates in treatment-resistant bipolar depression

    著者: Níall Lally, Allison C. Nugent, David A. Luckenbaugh, Rezvan Ameli, Jonathan P. Roiser, Carlos A. Zarate - Translational Psychiatry 2014 被引用: 266

  9. Neural correlates of change in major depressive disorder anhedonia following open-label ketamine

    著者: Níall Lally, Allison C. Nugent, David A. Luckenbaugh, Mark J. Niciu, Jonathan P. Roiser, Carlos A. Zarate - Journal of Psychopharmacology 2015 被引用: 223

  10. A Double-Blind, Placebo-Controlled Study of Memantine in the Treatment of Major Depression

    著者: Carlos A. Zarate, Jaskaran Singh, Jorge A. Quiroz, Georgette De Jesus, Kirk K. Denicoff, David A. Luckenbaugh, Husseini K. Manji, Dennis S. Charney - American Journal of Psychiatry 2006 被引用: 380

  11. Early-Onset Bipolar Disorder and Treatment Delay Are Risk Factors for Poor Outcome in Adulthood

    著者: Robert M. Post, Gabriele S. Leverich, Ralph Kupka, Paul E. Keck, Susan L. McElroy, Lori L. Altshuler, Mark A. Frye, David A. Luckenbaugh, Michael Rowe, Heinz Grunze, Trisha Suppes, Willem A. Nolen - The Journal of Clinical Psychiatry 2010 被引用: 361

  12. Improvement in suicidal ideation after ketamine infusion: Relationship to reductions in depression and anxiety

    著者: Elizabeth D. Ballard, Dawn F. Ionescu, Jennifer L. Vande Voort, Mark J. Niciu, Erica M. Richards, David A. Luckenbaugh, Nancy E. Brutsché, Rezvan Ameli, Maura L. Furey, Carlos A. Zarate - Journal of Psychiatric Research 2014 被引用: 285

  13. Course of Improvement in Depressive Symptoms to a Single Intravenous Infusion of Ketamine vs Add-on Riluzole: Results from a 4-Week, Double-Blind, Placebo-Controlled Study

    著者: Lobna Ibrahim, Nancy Diazgranados, Jose Franco‐Chaves, Nancy E. Brutsché, Ioline D. Henter, Phillip D. Kronstein, Ruin Moaddel, Irving W. Wainer, David A. Luckenbaugh, Husseini K. Manji, Carlos A. Zarate - Neuropsychopharmacology 2012 被引用: 310

  14. Effect of Baseline Anxious Depression on Initial and Sustained Antidepressant Response to Ketamine

    著者: Dawn F. Ionescu, David A. Luckenbaugh, Mark J. Niciu, Erica M. Richards, Elizabeth E. Slonena, Jennifer L. Vande Voort, Nancy E. Brutsché, Carlos A. Zarate - The Journal of Clinical Psychiatry 2014 被引用: 111

  15. Three times more days depressed than manic or hypomanic in both bipolar I and bipolar II disorder1

    著者: Ralph Kupka, Lori L. Altshuler, Willem A. Nolen, Trisha Suppes, David A. Luckenbaugh, Gabriele S. Leverich, Mark A. Frye, Paul E. Keck, Susan L. McElroy, Heinz Grunze, Robert M Post - Bipolar Disorders 2007 被引用: 391

  16. Change in cytokine levels is not associated with rapid antidepressant response to ketamine in treatment-resistant depression

    著者: Minkyung Park, Laura Newman, Philip W. Gold, David A. Luckenbaugh, Peixiong Yuan, Rodrigo Machado‐Vieira, Carlos A. Zarate - Journal of Psychiatric Research 2016 被引用: 88

  17. Symptomatology and predictors of antidepressant efficacy in extended responders to a single ketamine infusion

    著者: Steven Pennybaker, Mark J. Niciu, David A. Luckenbaugh, Carlos A. Zarate - Journal of Affective Disorders 2016 被引用: 76

  18. A Randomized Trial of a Low-Trapping Nonselective N-Methyl-D-Aspartate Channel Blocker in Major Depression

    著者: Carlos A. Zarate, Daniel C. Mathews, Lobna Ibrahim, Jose Franco Chaves, Craig A. Marquardt, Immaculata Ukoh, Libby Jolkovsky, Nancy E. Brutsché, Mark A. Smith, David A. Luckenbaugh - Biological Psychiatry 2012 被引用: 253

  19. A Randomized, Placebo-Controlled, Crossover Pilot Trial of the Oral Selective NR2B Antagonist MK-0657 in Patients With Treatment-Resistant Major Depressive Disorder

    著者: Lobna Ibrahim, Nancy Diazgranados, Libby Jolkovsky, Nancy E. Brutsché, David A. Luckenbaugh, W. Joseph Herring, William Z. Potter, Carlos A. Zarate - Journal of Clinical Psychopharmacology 2012 被引用: 215

  20. Clinical Predictors of Ketamine Response in Treatment-Resistant Major Depression

    著者: Mark J. Niciu, David A. Luckenbaugh, Dawn F. Ionescu, Sara Guevara, Rodrigo Machado‐Vieira, Erica M. Richards, Nancy E. Brutsché, Neal M. Nolan, Carlos A. Zarate - The Journal of Clinical Psychiatry 2014 被引用: 165

  21. Brain-Derived Neurotrophic Factor and Initial Antidepressant Response to anN-Methyl-D-Aspartate Antagonist

    著者: Rodrigo Machado‐Vieira, Peixiong Yuan, Nancy E. Brutsché, Nancy Diazgranados, David A. Luckenbaugh, Husseini K. Manji, Carlos A. Zarate - The Journal of Clinical Psychiatry 2009 被引用: 153

  22. Validation of digital spiral analysis as outcome parameter for clinical trials in essential tremor

    著者: Dietrich Haubenberger, Daniel Kalowitz, Fatta B. Nahab, Camilo Toro, Dominic Ippolito, David A. Luckenbaugh, Loretta Wittevrongel, Mark Hallett - Movement Disorders 2011 被引用: 117

  23. Repetitive TMS combined with exposure therapy for PTSD: A preliminary study

    著者: Elizabeth Osuch, Brenda E. Benson, David A. Luckenbaugh, Marilla Geraci, Robert M. Post, Una D. McCann - Journal of Anxiety Disorders 2008 被引用: 178

  24. Intermittent theta-burst transcranial magnetic stimulation for treatment of Parkinson disease

    著者: David Benninger, Brian D. Berman, Elise Houdayer, Natassja Pal, David A. Luckenbaugh, Logan Schneider, Suci Miranda, Mark Hallett - Neurology 2011 被引用: 173